Treatment of dermatophytoses by film-forming topical antifungal spray / Mohd Faiz Mustaffa by Mustaffa, Mohd Faiz




TOPICAL ANTIFUNGAL SPRAY 
MOHD FAIZ BIN MUSTAFFA 
Thesis submitted in fulfillment 
of the requirements for the degree of 
Master of Science 
Faculty of Pharmacy 
March 2016 
CONFIRMATION BY PANEL OF EXAMINERS 
I certify that a Panel of Examiners has met on 21s October 2015 to conduct the final 
examination on Mohd Faiz Mustaffa on his Master of Science thesis entiltled 
"Treatment of Dermatophytoses by Film-Forming Topical Antifungal Spray" in 
accordance with Universiti Teknologi MARA Act 1976 (Akta 173). The panel of 
Examiners recommends that the student be awarded the relevant degree. The panel of 
Examiners was as follows: 
Jean Frederic Faizal Weber, PhD 
Professor 
Faculty of Pharmacy 
Universiti Teknologi MARA 
(Chairman) 
Nor Amlizan Ramli, PhD 
Senior Lecturer 
Faculty of Pharmacy 
Universiti Teknologi MARA 
(Internal Examiner) 
Norazrina Azmi, PhD 
Senior Lecturer 
Faculty of Pharmacy 
Universiti Kebangsaan Malaysia 
(External Examiner) 
SITI HALIJJAH SHARIFF, PhD 
Associate Professor 
Dean 
Institute of Graduate Studies 
Universiti Teknologi MARA 
Date :24th March, 2016 
n 
AUTHOR'S DECLARATION 
I declare that the work in this thesis was carried out in accordance with the regulations 
of Universiti Teknologi MARA. It is original and is the results of my own work, 
unless otherwise indicated or acknowledged as referenced work. This thesis has not 
been submitted to any other academic institution or non-academic institution for any 
degree or qualification. 
I, hereby, acknowledge that I have been supplied with the Academic Rules and 
Regulations for Post Graduate, Universiti Teknologi MARA, regulating the conduct of 
my study and research. 
Name of student 




Mohd Faiz Bin Mustaffa 
2011680672 
Master of Science (Pharmacy) - PH780 
Pharmacy 
Treatment of Dermatophytoses by Film-Forming 
Topical Antifungal Spray 
Signature of Student : 
Date : March 2016 
iii 
ABSTRACT 
Dermatophytosis is a major public health problem especially in tropical countries like 
Malaysia. Several studies report incidence of resistance to common treatment for 
dermatophytosis with drugs such as terbinafine, fluconazole, and griseofulvin. 
Resistance arise as consequence of non-adherence with prescribed treatment regimens, 
repetitive use of antifungal drugs more than once in a patient's life, incidence of 
reabsorption or washout of drug from the skin and failure of drug to reach the stratum 
corneum. Currently available antifungal preparations (ointments or creams) are easily 
removed after application and may contribute to none cure and/or to development of 
resistance. This project was initiated with the intention of producing an antifungal 
topical drug delivery system using film-forming polymeric solutions. The research 
was divided into 4 main areas which are (1) preliminary studies to test antimicrobial 
activities and determine the cytotoxicity of selected antimicrobial drugs and natural 
product extracts in vitro, (2) formulation and characterization of film-forming 
solutions, (3) elucidate skin permeation of selected drug, (4) determine antifungal 
activity and safety profile of topical film forming polymeric spray. Seventy-three (73) 
formulations were prepared but only 6 formulations were chosen from the pre-
formulation studies were further testing. Formulation A was superior to the other 
tested formulations due dries in less than 1 minute, is non-sticky and forms a 
transparent film on the skin. The dried film of formulation A has significantly low in 
tensile strength (4.78±0.14 N/m2,/? value<0.05) indicating that it is flexible enough to 
follow the movement of skin and has a significantly high percentage elongation at 
break (13.61c ± 2.229 %, p value <0.05) which prevents loss of film through abrasion. 
Terbinafine HC1 content of Formulation A is acceptable according to British 
Pharmacopoeia specifications. Formulation A showed significantly (p value<0.05) the 
highest (151.038 |ig/cm2) drug permeation across SC at 24 hours and efficacious when 
compared to rest of the formulations and the proprietary drug [47.578 jag/cm2, 
Terbex® (cream formulation)]. Formulation A is a new method for topical antifungal 
delivery to treat dermatophytosis affecting skin with good patient acceptance for 
improved compliance, is efficacious, safe and satisfies pharmacopeal standards for 
product stability. 
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